RECRUITINGINTERVENTIONAL
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)
EnCoRe MoMS Aim 1: Develop and Implement a Community-informed Institutional Obstetric Sepsis Bundle
About This Trial
Sepsis is the second leading cause of maternal death in the U.S. Labor and postpartum are particularly vulnerable risk periods. The goal of this multi-center, multidisciplinary study is to evaluate a maternal sepsis safety bundle.
Who May Be Eligible (Plain English)
Who May Qualify:
Birthing Person (EMR evaluation):
-Delivery hospitalizations and associated postpartum readmissions at the 4 hospital sites between 2020-2025
Who Should NOT Join This Trial:
Birthing Person (EMR evaluation)
-Delivery hospitalizations (and associated postpartum readmissions)to a hospital other than the 4 hospital sites or outside of 2020-2025 timeframe
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
Birthing Person (EMR evaluation):
-Delivery hospitalizations and associated postpartum readmissions at the 4 hospital sites between 2020-2025
Exclusion Criteria:
Birthing Person (EMR evaluation)
-Delivery hospitalizations (and associated postpartum readmissions)to a hospital other than the 4 hospital sites or outside of 2020-2025 timeframe
Treatments Being Tested
BEHAVIORAL
Maternal Sepsis Safety Bundle
Maternal sepsis safety bundle implemented at Columbia, Lincoln, Harlem, and Allen hospitals.
Locations (4)
Columbia Unviersity Irving Medical Center
New York, New York, United States
NewYork-Presbyterian Allen Hospital
New York, New York, United States
NYC Health+Hospitals/Harlem
New York, New York, United States
NYC Health + Hospitals/Lincoln
The Bronx, New York, United States